XELODA 150 Pill - pink oval, 11mm
Generic Name: capecitabine
Pill with imprint XELODA 150 is Pink, Oval and has been identified as Xeloda 150 mg. It is supplied by Roche Laboratories.
Xeloda is used in the treatment of Colorectal Cancer; Breast Cancer, Metastatic; Pancreatic Cancer; Breast Cancer; Stomach Cancer and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Xeloda 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for XELODA 150
Xeloda
- Generic Name
- capecitabine
- Imprint
- XELODA 150
- Strength
- 150 mg
- Color
- Pink
- Size
- 11.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Antimetabolites
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Roche Laboratories
- Inactive Ingredients
-
croscarmellose sodium,
lactose anhydrous,
microcrystalline cellulose,
magnesium stearate,
water,
magnesium silicate,
titanium dioxide,
ferric oxide red,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00004-1100 | Roche |
| 54868-4143 (Discontinued) | Physicians Total Care Inc. (repackager) |
More about Xeloda (capecitabine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (32)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: antimetabolites
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.